Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

Re: Two questions re M402

Has anyone tried to handicap its chances?

Chances for commercial success? For eventually being approved? For advancing to phase-3? Please clarify your question.

What is the anticipated length of this trial phase?

Data from the first phase—i.e. the non-randomized dose-finding portion of the trial—is expected in 1H13, according to #msg-75150121. (This is also noted in #msg-76906028.)